Clarivate PLC (CLVT): Price and Financial Metrics

Clarivate PLC (CLVT): $6.79

0.07 (-1.02%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add CLVT to Watchlist
Sign Up

Industry: Technology - Services

Industry

C

Ranked

#57 of 79

in industry

CLVT Price/Volume Stats

Current price $6.79 52-week high $10.03
Prev. close $6.86 52-week low $6.07
Day low $6.59 Volume 9,266,018
Day high $6.81 Avg. volume 4,063,471
50-day MA $7.79 Dividend yield N/A
200-day MA $7.87 Market Cap 4.54B

CLVT Stock Price Chart Interactive Chart >


Clarivate PLC (CLVT) Company Bio


Clarivate Plc engages in the provision of trusted insights and analytics to accelerate the pace of innovation. It operates through the Science and Intellectual Property segments. The Science segment comprises the academic and life science product lines. The Intellectual Property segment includes patent, trademark, domain, and IP management product lines. The company was founded in 1864 and is headquartered in London.


CLVT Latest News Stream


Event/Time News Detail
Loading, please wait...

CLVT Latest Social Stream


Loading social stream, please wait...

View Full CLVT Social Stream

Latest CLVT News From Around the Web

Below are the latest news stories about CLARIVATE PLC that investors may wish to consider to help them evaluate CLVT as an investment opportunity.

Clarivate Reveals Stronger Outlook for Pulsed-field Ablation Market and Potential for Device to Revolutionize Treatment Paradigm

Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today announced the launch of a new special report series, Electrophysiology Mapping and Ablation Devices Market Insights. The Clarivate MedTech Insights reports reveal new forecast predictions for the ablation catheter market in four geographies: the US, Europe, Japan and Asia Pacific. Findings show pulsed-field ablation (PFA) is poised to revolutionize the

Yahoo | December 19, 2023

Clarivate Expands Partnership with VeriSIM Life to Accelerate and De-risk Research and Drug Development

Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today announced the launch of VeriSIM Life Translational Index™ on Cortellis Drug Discovery Intelligence by Clarivate. The integrated workflow provides customers with a diverse array of predictive compound safety and efficacy insights, including bioavailability, hepatic and renal clearance, clinical toxicity, first-in-human dose and more.

Yahoo | December 5, 2023

Clarivate Reveals World's Influential Researchers in Highly Cited Researchers 2023 List

Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today revealed its 2023 list of Highly Cited Researchers™ – influential researchers at universities, research institutes and commercial organizations around the world who have demonstrated significant and broad influence in their field(s) of research.

Yahoo | November 15, 2023

Clarivate to Present at the RBC Capital Markets 2023 Technology, Internet, Media and Telecommunications Conference on November 14, 2023

Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in connecting people and organizations to intelligence they can trust to transform their world, announced today that Jonathan Gear, Chief Executive Officer, will present at the RBC Capital Markets 2023 Technology, Internet, Media and Telecommunications Conference on Tuesday, November 14, 2023 at 1:20 pm Eastern Time.

Yahoo | November 8, 2023

Clarivate Reports Third Quarter 2023 Results

Clarivate Plc - (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today reported results for the third quarter.

Yahoo | November 7, 2023

Read More 'CLVT' Stories Here

CLVT Price Returns

1-mo -3.82%
3-mo -23.36%
6-mo 1.04%
1-year -24.72%
3-year -74.03%
5-year N/A
YTD -26.67%
2023 11.03%
2022 -64.54%
2021 -20.83%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!